| Page 1484 | Kisaco Research
 

Aleksandra Kovacevic

Director Privacy Management
HERE Technologies

Aleksandra is leading privacy-by-design efforts at HERE Technologies. After a decade R&D and product management in the area of Big Data analytics, fascinated by the conflicting needs to preserve the data value while protecting privacy, she started working on anonymization technologies for location data and expanded to privacy- and ethics-by-design enabling product differentiating capabilities.

Aleksandra Kovacevic

Director Privacy Management
HERE Technologies

Aleksandra Kovacevic

Director Privacy Management
HERE Technologies

Aleksandra is leading privacy-by-design efforts at HERE Technologies. After a decade R&D and product management in the area of Big Data analytics, fascinated by the conflicting needs to preserve the data value while protecting privacy, she started working on anonymization technologies for location data and expanded to privacy- and ethics-by-design enabling product differentiating capabilities.

 

Anjana Rao

Professor
La Jolla Institute of Immunology

Anjana Rao

Professor
La Jolla Institute of Immunology

Anjana Rao

Professor
La Jolla Institute of Immunology
 

Tanaz Sharifnia

Research Scientist
Broad Institute of Harvard and MIT

Tanaz Sharifnia is a research scientist and investigator in the Chemical Biology and Therapeutics Science Program at the Broad Institute of Harvard and MIT. Her research interests include applying systematic functional genomic and small-molecule-based approaches to discover and target cancer vulnerabilities. Working in close partnership with other scientists, clinicians, a medical research foundation, and patients, she seeks to translate basic research insights into new therapies for patients with intractable cancers. Dr. Sharifnia received her Ph.D.

Tanaz Sharifnia

Research Scientist
Broad Institute of Harvard and MIT

Tanaz Sharifnia

Research Scientist
Broad Institute of Harvard and MIT

Tanaz Sharifnia is a research scientist and investigator in the Chemical Biology and Therapeutics Science Program at the Broad Institute of Harvard and MIT. Her research interests include applying systematic functional genomic and small-molecule-based approaches to discover and target cancer vulnerabilities. Working in close partnership with other scientists, clinicians, a medical research foundation, and patients, she seeks to translate basic research insights into new therapies for patients with intractable cancers. Dr. Sharifnia received her Ph.D. in the field of cancer genomics from Harvard University.

 

Melinda Day

Associate Director Translational Clinical Operations
Kronos Bio

Melinda Day

Associate Director Translational Clinical Operations
Kronos Bio

Melinda Day

Associate Director Translational Clinical Operations
Kronos Bio
 

Jun Qin

Director
Beijing Proteome Research Center (BPRC)

Jun Qin

Director
Beijing Proteome Research Center (BPRC)

Jun Qin

Director
Beijing Proteome Research Center (BPRC)
 

Lindsay Pino

Co-Founder
Talus Biosciences

I’m a postdoctoral researcher with over a decade of experience in developing mass spectrometry proteomics methods for studying human disease. I’ve trained at the Broad Institute, the University of Washington, and most recently the University of Pennsylvania. My focus is on developing techniques for quantitative proteomics and in particular I’m interested in the challenges associated with scaling-up quantitative proteomics experiments. Lately, I’ve been working on expanding these techniques to target dynamic systems including protein turnover, epigenetics, and protein interactions.

Lindsay Pino

Co-Founder
Talus Biosciences

Lindsay Pino

Co-Founder
Talus Biosciences

I’m a postdoctoral researcher with over a decade of experience in developing mass spectrometry proteomics methods for studying human disease. I’ve trained at the Broad Institute, the University of Washington, and most recently the University of Pennsylvania. My focus is on developing techniques for quantitative proteomics and in particular I’m interested in the challenges associated with scaling-up quantitative proteomics experiments. Lately, I’ve been working on expanding these techniques to target dynamic systems including protein turnover, epigenetics, and protein interactions.

Outside of research, I am a runner, dog owner, and hiker. Although I completed my first full marathon in 2015, I mostly stick to 5-10k’s with my shelter dog now. I’m most at home in the mountains, especially backpacking. My latest hobby is perfecting my macaron recipe, thanks to the Great British Bake-Off.